-
Cefepime is a fourth-generation
cephalosporin antibiotic.
Cefepime has an
extended spectrum of
activity against Gram-positive and Gram-negative bacteria...
-
Cefepime/enmetazobactam, sold
under the
brand name Exblifep, is a
medication used for the
treatment of
urinary tract infections. It is a
fixed dose combination...
-
Pseudomonas aeruginosa (e.g.
cefepime), or
carbapenems (imipenem or meropenem). A
subsequent meta-analysis
published in 2006
found cefepime to be ****ociated with...
- the
breakdown of
other antibiotic drugs.
Cefepime Lanier C,
Melton T,
Covert K (September 2024). "
Cefepime-Enmetazobactam: A Drug
Review of a Novel...
- and
treatment with
cefepime is
recommended by the IDSA if
causing disease rather than
simply colonising.
Treatment using cefepime and
gentamicin has been...
-
enhanced activity against Gram-positive
bacteria and
Pseudomonas aeruginosa)
Cefepime Cefpirome (activity
against MRSA and
variably VRE. *Not
universally accepted...
- new,
related class called oxacephems.
Drugs included in this
group are
cefepime and cefpirome. Some
state that
cephalosporins can be
divided into five...
-
other oxyimino-beta-lactam
substrates (e.g., ceftazidime, ceftriaxone, or
cefepime).
Rather than
arising by mutation, they
represent examples of
plasmid acquisition...
-
shows that
there is
potential for
resistance evolution in
relation to
cefepime for both CMY-2 and TEM-1. The
resistance that is
gained by CMY-2 and TEM-1...
- –
nadifloxacin 1993 – panipenem/betamipron 1993 –
sparfloxacin 1994 –
cefepime 1996 –
meropenem 1999 – quinupristin/dalfopristin 2000 – linezolid, the...
